Published in Int J Dermatol on June 01, 1992
Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects. Clin Microbiol Rev (2006) 2.23
Phylogeny and PCR identification of the human pathogenic fungus Penicillium marneffei. J Clin Microbiol (1995) 1.38
Immunoreactivity of a 38-kilodalton Penicillium marneffei antigen with human immunodeficiency virus-positive sera. J Clin Microbiol (1997) 1.12
Different susceptibilities of yeasts and conidia of Penicillium marneffei to nitric oxide (NO)-mediated fungicidal activity of murine macrophages. Clin Exp Immunol (1998) 0.98
Diagnosis of Penicillium marneffei infection by quantitation of urinary antigen by using an enzyme immunoassay. J Clin Microbiol (1999) 0.97
Immunoperoxidase staining for identification of Aspergillus species in routinely processed tissue sections. J Clin Pathol (1996) 0.91
Development and evaluation of rapid urinary antigen detection tests for diagnosis of penicilliosis marneffei. J Clin Microbiol (2002) 0.86
Antigen detection assay for identification of Penicillium marneffei infection. J Clin Microbiol (2003) 0.82
Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J Clin Invest (1993) 2.45
The preparation and antimycotic properties of derivatives of 1-phenethylimidazole. J Med Chem (1969) 2.28
The clinical pharmacokinetics of itraconazole: an overview. Mycoses (1989) 2.27
Ketoconazole -- a new broad spectrum orally active antimycotic. Experientia (1979) 2.24
Azole resistance in Candida albicans. J Med Vet Mycol (1986) 2.17
Detection of circulating galactomannan by Pastorex Aspergillus in experimental invasive aspergillosis. Mycoses (1990) 2.01
Treatment of vaginal candidiasis with ketoconazole, a new, orally active, antimycotic. Eur J Obstet Gynecol Reprod Biol (1979) 2.01
Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients. J Clin Microbiol (1995) 1.96
Itraconazole, a new triazole that is orally active in aspergillosis. Antimicrob Agents Chemother (1984) 1.83
Antimycotic imidazoles. part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent. J Med Chem (1979) 1.78
Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis. Arch Dermatol (1994) 1.71
The influence of gastric acidity on the bio-availability of ketoconazole. J Antimicrob Chemother (1980) 1.68
Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models. Rev Infect Dis (1987) 1.64
Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect. Kidney Int (1994) 1.55
Restrictive dermopathy, a lethal form of arthrogryposis multiplex with skin and bone dysplasias: three new cases and review of the literature. Am J Med Genet (1992) 1.52
Immunohistochemical expression of galactomannan in the cytoplasm of phagocytic cells during invasive aspergillosis. Am J Clin Pathol (1991) 1.49
Promotion of pseudomycelium formation of Candida albicans in culture: a morphological study of the effects of miconazole and ketoconazole. Postgrad Med J (1979) 1.47
Dihydroxyacetone test as a substitute for the dansyl chloride test. Dermatology (1993) 1.45
Images in clinical medicine. A medical mystery. N Engl J Med (2001) 1.42
Epidermal interleukin-8 and its receptor CXCR2 in drug-induced toxic epidermal necrolysis. Clin Exp Dermatol (2007) 1.41
Factor-XIIIa-positive dendrocytes and the dermal microvascular unit. Dermatologica (1990) 1.40
Breast and lung cancers in two cyclosporin-A-treated psoriatic women. Dermatology (1998) 1.39
Neutrophilic eccrine hidradenitis. A case report. Acta Clin Belg (1993) 1.38
Gravitational syndrome and tensile properties of skin in the elderly. Dermatology (1998) 1.38
Revisiting dandruff. Int J Cosmet Sci (2006) 1.28
Antimycotic azoles. 7. Synthesis and antifungal properties of a series of novel triazol-3-ones. J Med Chem (1984) 1.27
Retrospective evaluation of two latex agglutination tests for detection of circulating antigens during invasive candidosis. J Clin Microbiol (1992) 1.21
Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi. Int J Dermatol (1992) 1.20
Ketoconazole in experimental candidosis. Rev Infect Dis (1981) 1.19
The pharmacokinetics of ketoconazole in severely immunocompromised patients. J Antimicrob Chemother (1982) 1.17
Treatment and prophylaxis of tinea infections. Drugs (1996) 1.16
Evidence for a relationship between Ehlers-Danlos type VII C in humans and bovine dermatosparaxis. Nat Genet (1992) 1.16
The antifungal activity of ketoconazole. Am J Med (1983) 1.15
Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole. Arch Dermatol (1996) 1.11
Cellulite: from standing fat herniation to hypodermal stretch marks. Am J Dermatopathol (2000) 1.07
Antimycotic azoles. 6. Synthesis and antifungal properties of terconazole, a novel triazole ketal. J Med Chem (1983) 1.07
Itraconazole versus griseofulvin in the treatment of tinea capitis: a double-blind randomized study in children. Int J Dermatol (1994) 1.07
The interaction of miconazole and ketoconazole with lipids. Biochem Pharmacol (1982) 1.06
Comparative immunohistochemical study of herpes simplex and varicella-zoster infections. Virchows Arch A Pathol Anat Histopathol (1993) 1.05
Treatment of drug-induced toxic epidermal necrolysis (Lyell's syndrome) with intravenous human immunoglobulins. Burns (2001) 1.04
The frequency of cutaneous vasculitis is not increased in patients with rheumatoid arthritis treated with methotrexate. J Rheumatol (1996) 1.02
Skin water-holding capacity and transdermal estrogen therapy for menopause: a pilot study. Maturitas (1995) 1.02
Experimental systemic dermatophytosis. J Invest Dermatol (1984) 1.01
Interleukin-6 and the skin. Int Arch Allergy Immunol (1996) 1.01
Seasonal modulation of sebum excretion. Dermatologica (1990) 1.01
The activity of ketoconazole in clinical isolates of candida albicans cultured in a mycelium promoting medium. Mykosen (1981) 1.01
Collision of primary malignant neoplasms on the skin: the connection between malignant melanoma and basal cell carcinoma. Dermatology (1997) 1.00
Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis. J Am Acad Dermatol (1992) 1.00
High-resolution epiluminescence colorimetry of striae distensae. J Eur Acad Dermatol Venereol (2006) 0.99
Culture media for the study of the effects of azole derivatives on germ tube formation and hyphal growth of C. albicans. Mykosen (1986) 0.98
Cellulite histopathology and related mechanobiology. Int J Cosmet Sci (2006) 0.97
Influence of body posture and gravitational forces on shear wave propagation in the skin. Dermatology (2001) 0.96
Erythema multiforme and toxic epidermal necrolysis: a comparative study. Am J Dermatopathol (1997) 0.95
Skin-lightening products revisited. Int J Cosmet Sci (2003) 0.94
Age- and body mass index-related changes in cutaneous shear wave velocity. Exp Gerontol (2001) 0.93
Effectors of inflammation in actinic prurigo. J Am Acad Dermatol (2001) 0.92
Oral treatment with ketoconazole in systemic candidosis of guinea-pigs: microbiology, hematology and histopathology. Sabouraudia (1985) 0.91
Effect of hormone replacement therapy for menopause on the mechanical properties of skin. J Am Geriatr Soc (1995) 0.89
Climacteric skin ageing of the face--a prospective longitudinal comparative trial on the effect of oral hormone replacement therapy. Maturitas (1999) 0.89
Sensitive skin at menopause; dew point and electrometric properties of the stratum corneum. Maturitas (1998) 0.89
Experimental cutaneous Candida albicans infection in guinea-pigs. Sabouraudia (1971) 0.89
Effect of the 585 nm flashlamp-pumped pulsed dye laser for the treatment of keloids. Dermatol Surg (2001) 0.89
Teloptosis, a turning point in hair shedding biorhythms. Dermatology (2001) 0.89
Comparison of the kinetics of sebum secretion in young women with and without acne. Dermatologica (1991) 0.88
From axioms to new insights into dandruff. Dermatology (2000) 0.88
The hair eclipse phenomenon: sharpening the focus on the hair cycle chronobiology. Int J Cosmet Sci (2003) 0.88
Skin climacteric aging and hormone replacement therapy. J Cosmet Dermatol (2006) 0.88
Viral glycoproteins in herpesviridae granulomas. Am J Dermatopathol (1994) 0.88
Cutaneous manifestations in systemic trichosporonosis. Clin Exp Dermatol (1992) 0.88
Low-productive alpha-herpesviridae infection in chronic lichenoid dermatoses. Dermatology (1998) 0.88
Localization of varicella-zoster virus nucleic acids and proteins in human skin. Neurology (1995) 0.87
Distribution of varicella zoster virus and herpes simplex virus in disseminated fatal infections. J Clin Pathol (1996) 0.87
Monoclonal antibodies to a specific 54-kilodalton antigen of Nocardia spp. J Clin Microbiol (1992) 0.87
[Immunohistochemical identification of Aspergillus by monoclonal antibody EB-A1]. Ann Pathol (1990) 0.87
The in-vitro antifungal spectrum of itraconazole. Mycoses (1989) 0.87
Patterns of follicular sebum excretion rate during lifetime. Arch Dermatol Res (1987) 0.87
Ketoconazole shampoo: effect of long-term use in androgenic alopecia. Dermatology (1998) 0.86
Facing up to the diagnostic uncertainty and management of onychomycoses. Int J Dermatol (1999) 0.86
Experimental zygomycosis due to Rhizopus spp. infection by various routes in guinea-pigs, rats and mice. Mycoses (1988) 0.86
[Pedunculated and pigmented basal cell carcinoma: an unusual presentation]. Rev Med Liege (2006) 0.86
Corneosurfametry: a predictive assessment of the interaction of personal-care cleansing products with human stratum corneum. Dermatology (1994) 0.85
Varicella-zoster virus vasculitis: a case of recurrent varicella without epidermal involvement. Dermatology (2000) 0.85
EEMCO guidance for the assessment of hair shedding and alopecia. Skin Pharmacol Physiol (2004) 0.85
Histologic study of delayed reactions to coelenterates. J Am Acad Dermatol (1990) 0.85
Fatal hyalohyphomycosis following Fusarium onychomycosis in an immunocompromised patient. Am J Dermatopathol (1996) 0.85
Skin in dermatosparaxis. Dermal microarchitecture and biomechanical properties. J Invest Dermatol (1976) 0.85
Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: a multicenter study with 36 patients. J Am Acad Dermatol (1997) 0.85
Adverse effects of topical corticosteroids. Acta Derm Venereol Suppl (Stockh) (1989) 0.85
In vivo confocal microscopy: a new paradigm in dermatology. Dermatology (1993) 0.85
Sister Mary Joseph's nodule and inaugural cutaneous metastases of gastrointestinal adenocarcinomas. Acta Clin Belg (1995) 0.84